
KRAS inhibitor-9
CAS No. 300809-71-6
KRAS inhibitor-9 ( DUN09716 )
产品货号. M22747 CAS No. 300809-71-6
KRAS抑制剂-9是一种有效的KRAS抑制剂,Kd为92 μM,可阻断GTP-KRAS的形成和KRAS下游的激活。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥632 | 有现货 |
![]() ![]() |
5MG | ¥988 | 有现货 |
![]() ![]() |
10MG | ¥1604 | 有现货 |
![]() ![]() |
25MG | ¥3013 | 有现货 |
![]() ![]() |
50MG | ¥4358 | 有现货 |
![]() ![]() |
100MG | ¥5589 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称KRAS inhibitor-9
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述KRAS抑制剂-9是一种有效的KRAS抑制剂,Kd为92 μM,可阻断GTP-KRAS的形成和KRAS下游的激活。
-
产品描述KRAS inhibitor-9 is a potent KRAS inhibitor with Kd of 92 μM that blocks the formation of GTP-KRAS and downstream activation of KRAS.??KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSCLC cells with KRAS mutation but not normal lung cells
-
体外实验KRAS inhibitor-9 bound to KRASG12D, KRAS G12C and KRAS Q61H protein with a moderate binding affinity of -5.38, -5.41, and -3.97 kcal/mol, respectively. KRAS inhibitor-9 (0-100 μM) shows strong inhibition selectivity in NSCLC cells with IC50s ranging from 39.56 to 66.02 μM for H2122, H358 and H460 cells (at 72 hours).KRAS inhibitor-9 (0-100 μM; 24 hours) blocks GTP-KRAS formation in H2122, H358 and H460 cells.KRAS inhibitor-9 (25-100 μM; 48 hours) inhibits the activation of KRAS downstream signaling pathway.KRAS inhibitor-9 (0-100 μM; 24-72 hours) induces cell cycle arrest and apoptosis in NSCLC. Cell Viability Assay Cell Line:H2122 (KRAS G12C), H358 (KRAS G12C) and H460 (KRAS Q61H) cell lines Concentration:0, 25, 50, 100 μM Incubation Time:24, 48, and 72 hoursResult:Inhibited three NSCLC cell lines in a dose- and time-dependent manner, but not in normal lung fibroblast cell line CCD-19Lu.Western Blot Analysis Cell Line:H2122, H358 and H460 cells Concentration:0, 25, 50, 100 μM Incubation Time:48 hours Result:Reduces the levels of phosphorylation of CRAF and AKT in a dose-dependent manner in H2122, H358 and H460 cells.Apoptosis Analysis Cell Line:H2122, H358, H460 cellsConcentration:0, 25, 50, 100 μM Incubation Time:24-72 hours Result:Significantly decreased in G0/G1 phase while remarkably increased in G2/M phase after 24 hours and induced a significantly increased apoptosis for 48h in NSCLC cell lines.
-
体内实验——
-
同义词DUN09716
-
通路MAPK/ERK Signaling
-
靶点Ras
-
受体KRAS
-
研究领域——
-
适应症——
化学信息
-
CAS Number300809-71-6
-
分子量292.8
-
分子式C13H9ClN2S2?
-
纯度>98% (HPLC)
-
溶解度DMSO:230 mg/mL?(785.49 mM;?Need ultrasonic)
-
SMILESNc1ccc(Sc2nc3ccccc3s2)c(Cl)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Xie C, et al. Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells. Front Pharmacol. 2017;8:823. Published 2017 Nov 14.
产品手册




关联产品
-
6H05 trifluoroacetat...
6H05是致癌突变体K-Ras(G12C)的选择性变构抑制剂。
-
K-Ras G12C-IN-3
突变型 K-ras G12C 的新型不可逆抑制剂。
-
ARS-1630
ARS-1630 是 ARS-1620 的 R 构象阻转异构体。